Clinical Trial Update: Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

View source ↗

Summary

A real-world study examining outcomes in patients with HER2-positive metastatic breast cancer who had prior treatment with trastuzumab deruxtecan (Enhertu). The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: HER2-positive Breast Cancer | Status: COMPLETED